| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-125,580 | -60,080 | -26,554 | ||||
Income (Loss) Attributable to Parent, before Tax | ||||||
-126,038 | -60,080 | - | ||||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||
Depreciation and amortization | ||||||
1,078 | 320 | 225 | ||||
Amortization of investments | ||||||
-686 | -218 | 0 | ||||
Amortization of debt issuance costs | ||||||
948 | 560 | 0 | ||||
Stock-based compensation | ||||||
6,484 | 1,728 | 499 | ||||
Loss on extinguishment of debt | ||||||
2,324 | 0 | - | ||||
Change in fair value of warrants | ||||||
-692 | -196 | -46 | ||||
Changes in operating assets and liabilities | ||||||
Trade accounts receivable | ||||||
-4,693 | 0 | -1,098 | ||||
Other accounts receivable | ||||||
1,634 | -1,670 | - | ||||
Prepaid expenses and other current assets | ||||||
-960 | -1,588 | -5 | ||||
Inventory | ||||||
-2,176 | 0 | - | ||||
Other assets | ||||||
-247 | 62 | -111 | ||||
Accounts payable | ||||||
4,737 | -1,110 | 661 | ||||
Other accrued liabilities | ||||||
8,912 | 5,630 | 1,703 | ||||
Accrued trade discounts and rebates | ||||||
1,375 | 0 | - | ||||
Accrued returns reserve | ||||||
1,957 | 0 | - | ||||
Deferred grant awards | ||||||
- | - | -29 | ||||
Deferred rent | ||||||
- | - | 0 | ||||
Other liabilities | ||||||
1,239 | 283 | - | ||||
Net cash used in operating activities | ||||||
-104,346 | -56,279 | -24,663 | ||||
Cash flows from investing activities | ||||||
Capital expenditures | ||||||
-1,107 | -1,510 | -700 | ||||
Purchases of investments | ||||||
-102,472 | -68,851 | 0 | ||||
Sales and maturities of investments | ||||||
101,196 | 2,100 | 0 | ||||
Net cash provided by (used in) investing activities | ||||||
-2,383 | -68,261 | -700 | ||||
Cash flows from financing activities | ||||||
Proceeds from Initial Public Offering | ||||||
0 | 98,325 | 0 | ||||
Payments for Initial Public Offering Costs | ||||||
0 | -9,422 | 0 | ||||
Proceeds from public offerings | ||||||
61,692 | 0 | - | ||||
Payments of public offering costs | ||||||
-4,465 | 0 | -495 | ||||
Proceeds from sale of Series C Preferred Stock | ||||||
0 | 4,438 | 35,475 | ||||
Payments for preferred stock issuance costs | ||||||
0 | -24 | - | ||||
Proceeds from issuance of long-term debt | ||||||
60,000 | 35,000 | 0 | ||||
Repayment of debt | ||||||
-35,000 | 0 | - | ||||
Payments of debt issuance costs | ||||||
-2,381 | -333 | 0 | ||||
Stock purchases from employee stock purchase plan | ||||||
532 | 0 | - | ||||
Proceeds from exercise of stock awards | ||||||
152 | 227 | 159 | ||||
Net cash provided by financing activities | ||||||
80,530 | 128,211 | 35,139 | ||||
Effect of Exchange Rate on Cash and Cash Equivalents | ||||||
2 | 0 | - | ||||
Increase in cash and cash equivalents | ||||||
-26,197 | 3,671 | 9,776 | ||||
Supplemental schedule of cash flow information | ||||||
Cash paid for interest | ||||||
3,717 | 1,711 | 2 | ||||
Supplemental schedule of non-cash investing and financing activities | ||||||
Tenant improvement allowance | ||||||
5,658 | 0 | - | ||||
Accrued debt issuance costs | ||||||
1,800 | 2,325 | 0 | ||||
Allocation of debt proceeds to warrants | ||||||
0 | 1,012 | 0 | ||||
Vesting of early exercised awards | ||||||
- | - | 0 | ||||